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2"
i. Summary/Abstract 1"
Ubiquitylation is a reversible post-translational modification that is critical for most, if not 2"
all, cellular processes and essential for viability. Ubiquitin conjugates to substrate proteins 3"
either as a single moiety (monoubiquitylation) or as polymers composed of ubiquitin 4"
molecules linked to each other with various topologies and structures (polyubiquitylation). 5"
This contributes to an elaborated ubiquitin code that is decrypted by specific ubiquitin-6"
binding proteins. Indeed, these different types of ubiquitylation have different functional 7"
outcomes, notably affecting the stability of the substrate, its interactions, its activity or its 8"
subcellular localization. In this chapter, we describe protocols to determine whether a 9"
protein is ubiquitylated, to identify the site that is ubiquitylated, and provide direction to 10"
study the topology of the ubiquitin modification, in the yeast Saccharomyces cerevisiae. 11"
 12"
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3"
1. Introduction  22"
The conjugation of ubiquitin (hereafter referred to as “ubiquitylation”) is a complex 23"
modification that can alter a protein’s ability to interact with other proteins, and as such 24"
impacts on its stability, localization or function [1]. Ubiquitin is generally conjugated on the 25"
ε-amino group of lysine residues of the target substrates, also called monoubiquitylation. 26"
However, ubiquitin possesses itself 8 amino- groups (N-terminal + 7 lysines) that can be 27"
used for ubiquitin conjugation, thereby generating a poly-ubiquitin chain 28"
(polyubiquitylation). Hence, several factors will contribute to the signal generated by 29"
ubiquitylation, such as the identity of the residue targeted by ubiquitin on the substrate, the 30"
type of modification: mono- vs. polyubiquitylation, and in the latter case, the topology of the 31"
chain (i.e. which lysine residue of ubiquitin is used for chain elongation) and its length [1]. 32"
Various ubiquitin-binding domains contribute to the decoding of this modification [2]. 33"
Consequently, different types of ubiquitylation create a wide range of molecular signals that 34"
can lead to various functional outcomes, and altogether ubiquitylation contributes to many, 35"
if not all, cellular pathways.  36"
Ubiquitin is best known for its role as a signal for the recognition and subsequent 37"
degradation of target proteins by the proteasome, which is mainly mediated by K48-linked 38"
polyubiquitin chains. However, chains of all ubiquitin linkages have been identified and the 39"
study of their structure and function is still undergoing [3]. K63-linked polyubiquitylation is 40"
notably well known for its role in DNA repair [4-6], the regulation of signaling pathways [7] 41"
or membrane trafficking [8,9]. Although K48-linked polyubiquitylation represents only a 42"
fraction of the possible combinations of the ubiquitin code, it is the most abundant in all 43"
cells studied to date [10-14]. This type of ubiquitylation is often a transient event in the cell, 44"
occurring before the target protein is degraded, and can therefore be difficult to detect 45"
experimentally. 46"
4"
Furthermore, ubiquitylation is a reversible modification. Several family of proteases act 47"
as ubiquitin isopeptidases that cleave ubiquitin off substrates and process ubiquitin chains, 48"
allowing a fine regulation of the ubiquitylation signal [15]. Therefore, another technical 49"
problem when studying protein ubiquitylation is due to the activity of these enzymes when 50"
preparing a protein extract in native conditions (eg. during an immunoprecipitation).  51"
Here, we describe a protocol that allows the identification of ubiquitylated proteins in 52"
denaturing conditions in yeast. This is based on a construct allowing the expression of 53"
polyhistidine-tagged ubiquitin, which allows the purification of ubiquitylated proteins in 54"
denaturing conditions by immobilized metal-ion affinity chromatography (IMAC).  55"
Evidence that a protein is ubiquitylated can also be obtained by performing the reverse 56"
experiment, in which a protein of interest is immunoprecipitated and the resulting sample is 57"
blotted with anti-ubiquitin antibodies. In this type of experiment, the immunoprecipitation 58"
should be performed on denatured samples, to ensure that the ubiquitylation signal detected 59"
originates from the protein considered, and not from its potential interactants. Therefore, we 60"
describe another protocol to achieve immunoprecipitation in denaturing conditions.  61"
The identification of ubiquitylated sites on a protein of interest is often instrumental to 62"
understand the functional contribution of this modification. We describe two possible 63"
approaches that can lead to the identification of the ubiquitylation site on a protein. The first 64"
approach is a tandem purification procedure to purify the protein of interest in denaturing 65"
conditions. This may be helpful to identify ubiquitylation sites by mass spectrometry. We 66"
also describe a general, truncation-based genetic method to identify the ubiquitylated sites 67"
on a protein. 68"
Finally, we will discuss on the possibilities offered to define the topology of ubiquitin 69"
modification (linkage used within an ubiquitin chain on a substrate) and will provide an 70"
5"
example using a set of yeast strains carrying ubiquitin mutations, developed in the Finley lab 71"
[5]. 72"
 73"
 74"
2. Materials 75"
Prepare all solutions using ultrapure water (prepared by purifying deionized water to attain a 76"
sensitivity of 18 MΩ cm at 25°C) and analytical grade reagents. Prepare and store all 77"
reagents at room temperature (unless indicated otherwise). 78"
2.1 Components required for the visualization of ubiquitylation on crude extracts  79"
(Section 3.1) 80"
1. Yeast culture medium (synthetic complete medium, SC): 1.7 g/L yeast nitrogen base , 81"
5 g/L ammonium sulfate , 20 g/L glucose). Autoclave. Add sterile-filtered amino 82"
acid solution as required (e.g. dropout bases from Elis Solutions, Erpent, Belgium). 83"
2. Plasmid encoding His-tagged ubiquitin (see section 3.1) 84"
3. 100% TCA (Trichloroacetic acid) solution (w/v, i.e. 6.1 M). Store at 4°C. 85"
4. 10% TCA (Trichloroacetic acid) solution (w/v, i.e. 0.61 M). Store at 4°C. 86"
5. Vortex equipped with a microtube foam insert (placed in a cold room) 87"
6. Glass beads: 0.4-0.6 mm (BBI-8541701, Sartorius Mechatronics) 88"
7. Needles: 23G x 1” – 0.6 x 25 mm (Terumo Medical Corporation) 89"
8. 5x Sample buffer (250 mM Tris-HCl pH 6.8, 500 mMdithiothreitol , 10% SDS , 90"
0.01% bromophenol blue ,50% glycerol). Store at -20°C. 91"
9. 1M Tris-base: 1M Tris, non-buffered, in water. 92"
6"
10. 1x Sample buffer for TCA precipitates: 1 vol. of 5x Sample buffer , 1 vol. of Tris-93"
base, and 3 vol. water. Store at -20°C. 94"
11. General equipment for SDS-PAGE and western blotting (gel casting, solutions, tanks 95"
for migration/transfer, nitrocellulose membrane etc.) 96"
12. Antibody directed against the protein of interest (or its tag if applicable) 97"
2.2 Components required for the purification of ubiquitin conjugates using poly-His-98"
tagged ubiquitin (Section 3.2) 99"
1. Yeast culture medium (synthetic complete medium, SC): 1.7 g/L yeast nitrogen base, 100"
5 g/L ammonium sulfate, 20 g/L glucose). Autoclave. Add sterile-filtered amino acid 101"
solution as required (e.g. dropout bases from Elis Solutions, Erpent, Belgium). 102"
2. Plasmid encoding His-tagged ubiquitin (see section 3.1) 103"
3. 100% TCA (Trichloroacetic acid) solution (w/v, i.e. 6.1 M). Store at 4°C. 104"
4. 10% TCA (Trichloroacetic acid) solution (w/v, i.e. 0.61 M). Keep at 4°C. 105"
5. Glass beads: 0.4-0.6 mm (BBI-8541701, Sartorius Mechatronics) 106"
6. Vortex equipped with a microtube foam insert (placed in a cold room) 107"
7. Needles: 23G x 1” – 0.6 x 25 mm (Terumo Medical Corporation) 108"
8. 1M Tris-base: 1 M Tris, non-buffered, in water. 109"
9. Buffer A: 6 M Guanidium-HCl, 20mM Tris pH8.0, 100 mM K2HPO4, 10 mM 110"
imidazole, 100 mM NaCl, 0.1% Triton X-100 (v/v). 111"
10. Ni-NTA superflow (Qiagen) 112"
11. Micro Bio-Spin™ Chromatography Column (Bio-Rad)  113"
12. Wash1 buffer: 20 mM Tris pH8.0, 100 mM K2HPO4, 20 mM imidazole, 100 mM 114"
NaCl, 0.1% Triton X-100 (v/v). 115"
13. Wash2 buffer:  20mM Tris pH8.0, 100 mM K2HPO4, 10 mM imidazole, 1 M NaCl, 116"
0.1% Triton X-100 (v/v). 117"
7"
14. Elution buffer: 20 mM Tris pH8.0, 100 mM K2HPO4, 500 mM imidazole, 100 mM 118"
NaCl. Store at 4°C for no longer than a month. 119"
15. 5x Sample buffer: Tris-HCl 250 mM pH 6.8, dithiothreitol 500 mM, SDS 10%, 120"
bromphenol blue 0.01%, glycerol 50%. Store at -20°C. 121"
16. 100% acetone, ice-cold. 122"
13. Ponceau S solution: 0.2% ponceau S (w/v), 3% TCA (w/v). Store at 4°C. 123"
14. General equipment for SDS-PAGE and western blotting (gel casting, solutions, tanks 124"
for migration/transfer, nitrocellulose membrane etc.) 125"
15. Antibody directed against ubiquitin (e.g. mouse monoclonal P4D1 antibody: sc-126"
8017, Santa Cruz Biotech; use at 1/10000) and the protein of interest (or its tag if 127"
applicable). Store at 4°C or -20°C. 128"
2.3 Components required for immunoprecipitation in denaturing conditions (Section 129"
3.3) 130"
1. Yeast culture medium (synthetic complete medium, SC): yeast nitrogen base 1.7 g/L, 131"
ammonium sulfate 5g/L, glucose 2% w/v). Autoclave. Add sterile-filtered amino 132"
acid solution as required (e.g. dropout bases from Elis Solutions, Erpent, Belgium). 133"
2. 10% TCA (Trichloroacetic acid) solution (w/v, i.e. 0.61 M). Keep at 4°C. 134"
3. Vortex equipped with a microtube foam insert (placed in a cold room) 135"
4. Glass beads: 0.4-0.6 mm (BBI-8541701, Sartorius Mechatronics) 136"
5. Needles: 23G x 1” – 0.6 x 25 mm (Terumo Medical Corporation) 137"
6. Protein-G-coupled Sepharose (e.g. GammaBind™ G sepharose™, GE Healthcare), 138"
or if using an HA-tag, anti-HA affinity matrix (Roche) 139"
7. IP dilution buffer: 50 mM Tris pH 7.5, 2 mM EDTA, 100 mM NaCl, 1.2 % Triton 140"
X-100, 0.5 % Bovine Serum Albumin, yeast protease inhibitor cocktail (e.g. Sigma 141"
8"
P821520, diluted 1:100), 20 mM N-ethylmaleimide. Store at 4°C for no more than a 142"
week. 143"
8. Buffer B0: SDS 2% (w/v), bromophenol blue 0.05 % (w/v). 144"
9. Buffer B1: 50 mM Tris pH 7.5, 2 mM EDTA, 100 mM NaCl, 1 % Triton X-100, 0.2 145"
% SDS. Store at 4°C. 146"
10. Buffer B2: 50 mM Tris pH 7.5, 2 mM EDTA, 100 mM NaCl, 0.1 % Triton X-100, 147"
0.5 % SDS, 0.5 % Na-deoxycholate. Store at 4°C. 148"
11. Buffer B3: 50 mM Tris pH 7.5, 2 mM EDTA, 500 mM NaCl, 0.1 % Triton X-100. 149"
Store at 4°C. 150"
12. Buffer B4: 50 mM Tris pH 7.5, 2 mM EDTA, 100 mM NaCl. Store at 4°C. 151"
13. 5x Sample buffer: Tris-HCl 250 mM pH 6.8, dithiothreitol 500 mM, SDS 10%, 152"
bromphenol blue 0.01%, glycerol 50%. Store at -20°C. 153"
16. 100% acetone, ice-cold. 154"
17. 1x Sample buffer: 1 vol. 5x Sample buffer, 4 vol. water. Store at -20°C. 155"
18. General equipment for SDS-PAGE and western blotting (gel casting, solutions, tanks 156"
for migration/transfer, nitrocellulose membrane etc.) 157"
19. Antibody directed against the protein of interest (or its tag if applicable) and against 158"
ubiquitin (e.g. mouse monoclonal P4D1 antibody: sc-8017, Santa Cruz Biotech; use 159"
at 1/10000 ; or sc-8017 HRP, Santa Cruz Biotech; use at 1/2000). Store at 4°C or -160"
20°C. 161"
2.4. Components required for the tandem purification of a protein in denaturing 162"
conditions for the identification of ubiquitin-conjugated sites (Section 3.4)  163"
1. Yeast culture medium: synthetic complete medium (SC): yeast nitrogen base 1.7 g/L, 164"
ammonium sulfate 5g/L, glucose 2% w/v). Autoclave. Add required aminoacid as 165"
sterile-filtered solutions (e.g. CSM-Ura dropout, Elis Solutions, Erpent, Belgium). 166"
9"
2. Yeast culture medium: synthetic complete raffinose medium: yeast nitrogen base 1.7 167"
g/L, ammonium sulfate 5g/L, raffinose (2% w/v), 0.02% glucose (w/v) (see Note 1).  168"
3. Galactose solution, 20% (w/v), sterile-filtered. 169"
4. pBG1805-based plasmid containing the protein of interest (commercially available at 170"
OpenBiosystems/GE Healthcare Dharmacon). 171"
5. Protein-G-coupled Sepharose (e.g. GammaBind™ G sepharose™, GE Healthcare). 172"
6. IP lysis buffer: 50 mM HEPES-KOH pH7.5, 0.25M NaCl, 10% glycerol, 1mM 173"
EDTA. Filter sterilize and store at 4°C. 174"
7. Protease inhibitors: yeast protease inhibitor cocktail (Sigma P821520; use at 1:100 175"
dilution, store at -20°C), phenylmethanesulfonyl fluoride (PMSF) (100 mM stock in 176"
EtOH; store at -80°C), N-ethylmaleimide (NEM) (1 M stock in EtOH; store at -177"
80°C), and MG-132 (Enzo Life Sciences; 100 mM stock in DMSO; store at -80°C). 178"
8. Antibodies directed against the HA tag (e.g. mouse monoclonal F7 antibody: sc-179"
7392, Santa Cruz Biotech). Store at 4°C or -20°C. 180"
9. Glass beads: 0.4-0.6 mm (BBI-8541701, Sartorius Mechatronics) 181"
10. Vortex equipped with a microtube foam insert (placed in a cold room) 182"
11. Needles: 23G x 1” – 0.6 x 25 mm (Terumo Medical Corporation) 183"
12. Triton X-100 solution: 25% (v/v) in water. 184"
13. Urea buffer: urea 8M, 10 mM Tris pH 6.3; 5 mM imidazole, 10 mM beta-185"
mercaptoethanol, 10 mM N-ethylmaleimide, 100 µM MG-132. 186"
14. Ni-NTA superflow (Qiagene)  187"
15. 5x Sample buffer: 250 mM Tris-HCl pH 6.8, 500 mM dithiothreitol, 10% SDS, 188"
0.01% bromphenol blue, 50% glycerol. Store at -20°C. 189"
16. Urea elution buffer: 8M urea , 10 mM Tris pH 6.3, 600 mM imidazole. Store at 4°C. 190"
17. General equipment for SDS-PAGE and western blotting (gel casting, solutions, tanks 191"
10"
for migration/transfer, nitrocellulose membrane etc.) 192"
18. Antibodies directed against ubiquitin (e.g. mouse monoclonal P4D1 antibody: sc-193"
8017, Santa Cruz Biotech; use at 1/10000 ; or sc-8017 HRP, Santa Cruz Biotech; use 194"
at 1/2000). Store at 4°C or -20°C. 195"
 196"
3. Methods 197"
3.1. Obtaining evidence of ubiquitylation on crude extracts. 198"
When detecting the protein of interest by western blot, higher molecular weight species are 199"
sometimes observed, which may be caused by post-translational modifications such as 200"
ubiquitylation. The expression of a tagged (i.e. heavier) ubiquitin causes a shift in all 201"
ubiquitin-conjugated species, which can sometimes be sufficient to obtain a first indication 202"
that a given protein is ubiquitylated. Several plasmids available for this application have 203"
been described in the literature, either driving the expression of His-tagged ubiquitin under 204"
the control of a copper inducible promoter (pJD421, pYEp96– 6His-Ub)[16,17] or the 205"
strong ADH1 promoter (m886) [11]. Note that His-tagged ubiquitin was previously shown to 206"
be functionally comparable to non-tagged ubiquitin [18]. For expression of His-tagged 207"
ubiquitin driven by the CUP1 promoter, we noticed that the traces of copper in the synthetic 208"
medium (DO) are sufficient to drive the expression of His-Ub to a level comparable as 209"
endogenous Ub and therefore we recommend not to add extra copper in the medium to avoid 210"
potential artifacts that may be due to a massive ubiquitin overexpression.  211"
Therefore, this protocol describes a classical method to prepare crude extracts from cells 212"
expressing tagged ubiquitin or not, that may allow to determine whether a shift in molecular 213"
weight is due to ubiquitylation. The example of a result is illustrated in Figure 1. 214"
11"
1. DAY 1. In the morning, inoculate freshly streaked yeast cells in synthetic medium 215"
(SC) medium supplemented with the required amino-acids (preculture). Use a strain 216"
expressing your protein of interest together with His-tagged ubiquitin, and as a 217"
control, use the same strain but that does not contain the His-tagged ubiquitin 218"
plasmid. 219"
2. In the evening, measure the OD600 of the cultures and inoculate yeast cells in 5 mL 220"
SC medium, at OD600= 0.001. Grow overnight under agitation (200 rpm) at 30°C 221"
3. DAY 2. Measure the OD600 of the cultures. The cultures should have reached an 222"
OD600 of ~0.3-0.5. (see Note 2).  223"
4. Take 1 mL of culture and place in a 1.5 mL tube. 224"
5. Add 100 µL of a 100% (w/v) TCA solution 225"
6. Incubate on ice for 10 min. 226"
7. Spin down the cells by centrifugation for 1 min at 13,000 g at room temperature 227"
8. Discard the supernatant. 228"
9. Resuspend yeast cells in 100 µL of a 10% TCA solution 229"
10. Add glass beads up to 1-2 mm below the meniscus 230"
11. Lyse cells on a vortex equipped with a microtube foam insert for 10 min at 4°C.! 231"
12. After lysis, open the tube, poke a small hole at the bottom of the tube using a needle 232"
(Terumo 23 G x 1" - 0.6 x 25 mm), place into a clean 1.5-mL tube to collect the 233"
lysate, and close the cap 234"
13. Centrifuge for a few seconds on a mini-centrifuge to collect the lysate and leave the 235"
beads in the upper tube. Discard the tube with the beads (they should be dry).  236"
14. Centrifuge the lysate for 1 min at 13 000 g at RT.  237"
15. Remove as much supernatant as possible.  238"
12"
16. Resuspend the pellet in 1x Laemmli buffer for TCA precipitates, considering that 1 239"
OD600 unit should be resuspended in 50 µL 240"
17. Denature at the desired temperature (37°C-95°C) for 5-10 min. 241"
18. Use 7 µL for SDS-PAGE and transfer onto nitrocellulose membrane. 242"
19. Blot with antibodies directed against the protein of interest. 243"
 244"
3.2. Purification of ubiquitin conjugates using polyHis-tagged ubiquitin 245"
In this protocol, total ubiquitin conjugates from cells will be purified by immobilized metal-246"
ion affinity chromatography. The presence of the protein of interest in this fraction is 247"
addressed using a specific antibody (against the protein of interest or a tag). The advantage 248"
of this purification is that it does not involve antibodies during the purification procedure, 249"
which may interfere when revealing the presence of the protein of interest by western 250"
blotting. It is also amenable to proteome-wide, mass spectrometry-based studies either alone 251"
[11,19] or in combination to additional purification procedures [20-22]. 252"
This protocol (based on [11], and slightly modified in [23]) requires the prior transformation 253"
of the yeast strain with a plasmid expressing His-tagged ubiquitin, described in the previous 254"
section. Other protocols using slightly different procedures have been described in the past 255"
[24,25]. Please note that this technique is not suitable to study the ubiquitylation of proteins 256"
that contains an endogenous His-stretch, as their purification on the Ni-NTA column will 257"
not depend on their ubiquitylation. A list of the S. cerevisiae proteins containing endogenous 258"
poly-histidine (≥5) stretches is displayed in table 1. Of note, Figure 2 shows the purification 259"
of one of these proteins, Snf1, on Ni-NTA beads even in the absence of His-tagged ubiquitin. 260"
13"
1. DAY 1. Preculture: inoculate freshly streaked yeast cells in synthetic medium (DO) 261"
medium supplemented with the required amino-acids in the morning. Use a strain 262"
expressing your protein of interest together with His-tagged ubiquitin, and as a 263"
control, use the same strain but that does not contain the His-tagged ubiquitin 264"
plasmid. 265"
2. In the evening, measure the OD600 of the cultures and inoculate yeast cells in 100 mL 266"
DO medium, at OD600= 0.001. Grow overnight under agitation (200 rpm) at 30°C. 267"
3. DAY 2. Measure the OD600 of the cultures. The cultures should have reached an 268"
OD600 of ~0.3-0.5. (see Note 2). Spin down the cells in 2x50 mL tubes (3000 g, 3 269"
min), remove the supernatant, place on ice. 270"
4. Resuspend each pellet in 500 µL 10% TCA (w/v; i.e. 0.61 N), pool into a 1.5 mL 271"
tube. 272"
5. Leave on ice for at least 10 min (up to a few days). 273"
6. Pellet cells: 1 min, 13 000 g at room temperature. 274"
7. Resuspend the precipitated cells with 100 µL of 10% TCA by pipetting. 275"
8. Add glass beads up to 1-2 mm below the meniscus. 276"
9. Lyse cells on a vortex equipped with a microtube foam insert for 20 min at 4°C.! 277"
10. After lysis, open the cap, poke a small hole at the bottom of the tube using a needle, 278"
place into a clean 1.5-mL tube to collect the lysate, and close the cap. 279"
11. Centrifuge for a few seconds on a mini-centrifuge to collect the lysate and leave the 280"
beads in the upper tube. Discard the tube with the beads (they should be dry). For 281"
complete recovery, the glass beads can be washed with 200 µL of cold 10% TCA if 282"
necessary, in this case, repeat the spin and pool with the first lysate.  283"
12. Centrifuge the lysate for 10 min at 13 000 g at 4°C.  284"
13. Remove as much supernatant as possible.  285"
14"
14. Wash the pellet with 100% ice-cold acetone, and centrifuge again for 10 min at 13 286"
000 g at 4°C. 287"
15. Neutralize the residual TCA present in the pellet by adding 30 µL of 1M Tris (non-288"
buffered) to the pellet. (see Note 4). 289"
16. Add 200 µl of buffer A. 290"
17. Resuspend the pellet. Add a few glass beads that will help to break the pellet, and 291"
vortex. (see Note 5).  292"
18. Add 800 µL buffer A to the resuspended pellet. 293"
19. Let solubilize further by rotating for 1h at room temperature. Resuspension should be 294"
complete. 295"
20. Transfer the lysate to a new tube and centrifuge for 10 min at 13 000 g, at room 296"
temperature. (see Note 6).  297"
21. During the centrifugation, prepare Ni-NTA beads (Qiagene): transfer 200µL slurry to 298"
2-mL tubes, wash the beads twice with 1.8 mL buffer A. Centrifuge for 1 min at 1 299"
000 g between each wash. (see Note 7). 300"
22. From the centrifugation (step 20), keep the supernatant, which corresponds to the 301"
solubilized lysate, and transfer to a new tube. Keep 25 µL aside, at room 302"
temperature, for TCA precipitation (“input fraction”) (see step 35). 303"
23. Add the remaining sample to the tube containing the washed beads (see step 21), and 304"
rotate for 2h at RT.  305"
24. Centrifuge for 30 sec at 500 g to spin down the beads. Collect 25 µL of unbound 306"
fraction and keep at room temperature for TCA precipitation (“Unbound fraction”) 307"
(see step 35). Discard remaining supernatant. 308"
25. Resuspend the beads in 1.8 mL buffer A 309"
15"
26. Transfer to a micro chromatography column placed in a tube holder (eg. floating 310"
foam rack placed on top of a beaker), and let the wash solution drop by gravity. 311"
27. Wash again with 1.8 mL buffer A, twice 312"
28. Wash with 1.8 mL Wash1 buffer, three times 313"
29. Wash with 1.8 mL Wash2 buffer, three times 314"
30. Place the micro chromatography column in a 1.5 mL tube, centrifuge for 10 sec at 315"
1000 g.  316"
31. Place the micro chromatography column in a clean 1.5 mL tube, and add 100 µL 317"
elution buffer to the beads.  318"
32. Incubate for 5 min at RT. 319"
33. Spin down eluate for 1 min at 1 000 g, at room temperature. 320"
34. Add 25 µL of 5x SDS sample buffer and denature at the desired temperature (37°C-321"
95°C) for 5-10 min. 322"
35. To prepare the “input” (see step 22) and “unbound” (see step 24) fraction, proceed as 323"
follows. Dilute the 25 µL-samples with 1.8 mL water, add 200 µL of 100% TCA and 324"
keep on ice for 10 min.  325"
36. Spin down for 10 min at 13 000 g, at 4°C.  326"
37. Discard supernatant. Wash the pellet with 1 mL ice-cold acetone (100%). 327"
38. Spin down for 1 min at 13 000 g, at 4°C.  328"
39. Discard supernatant. Let at room temperature with cap open until acetone has 329"
evaporated completely. 330"
40. Resuspend in 25 µL of sample buffer for TCA precipitates and denature at the 331"
desired temperature (37°C-95°C) for 5-10 min. 332"
16"
41. For SDS-PAGE, use 4 µL of input / unbound fractions as prepared above, and 3-7 333"
µL of the eluate (depending on the expression level of the protein and its rate of 334"
ubiquitylation). (see Notes 8 and 9).  335"
42. Transfer on nitrocellulose membrane. After transfer, performing a staining of the 336"
transferred proteins with a Ponceau S solution should allow to see His-Ub and a 337"
ladder of ubiquitylated proteins (Figure 3A). 338"
43. Blot with the antibody used to detect the protein of interest and with anti-Ubiquitin 339"
antibodies (e.g. mouse monoclonal P4D1 antibody: sc-8017, Santa Cruz Biotech; 340"
1/10000) to reveal Ub conjugates. 341"
 342"
 343"
3.3. Assessment of protein ubiquitylation after immunoprecipitation in denaturing 344"
conditions 345"
The previous method involves the expression of tagged ubiquitin and the affinity 346"
purification of ubiquitin conjugates, prior to detecting the presence of the protein of interest 347"
within this fraction. Performing the opposite experiment, i.e. by immunoprecipitating the 348"
protein of interest and studying the presence of ubiquitin in the immunoprecipitate, can also 349"
provide evidence of the ubiquitylation of a given protein. A main caveat of this approach is 350"
the fact that the ubiquitin signal detected in the immunoprecipitated sample may either be 351"
due to the protein that was immunoprecipitated, or to potential interactants that were co-352"
immunoprecipitated. Therefore, we provide a protocol that allows the immunoprecipitation 353"
of proteins in denaturing conditions, that was successfully used in the past [26,27]. These 354"
immunoprecipitates can be used to reveal the ubiquitylation of the protein of interest. 355"
17"
An advantage of this technique is that is does not involve the use of overexpressed tagged-356"
ubiquitin, and as such may be more physiologically relevant. However, it depends on the use 357"
of anti-ubiquitin antibodies, which also have their limits since some are specific of the 358"
topology of the ubiquitin modification. We routinely use the P4D1 monoclonal antibody, 359"
which is a good compromise for the detection of both mono- and poly-ubiquitin 360"
modifications, although the monoubiquitylation signal is sometimes weak (see for instance 361"
[28]).   362"
1. DAY 1. Preculture: inoculate freshly streaked yeast cells in synthetic medium (DO) 363"
supplemented with the required amino-acids in the morning. As a control, use a 364"
strain which does not express the tagged protein, to confirm that the ubiquitin signal 365"
observed after the immunoprecipitation is specific for the presence of the tagged 366"
protein. 367"
2. In the evening, measure the OD600 of the cultures and inoculate the yeast cells in 100 368"
mL DO medium, at OD600= 0.001. Grow overnight under agitation (200 rpm) at 369"
30°C. 370"
3. DAY 2. Measure the OD600 of the cultures. The cultures should have reached an 371"
OD600 of ~0.3-0.5. (see Note 2). Spin down the cells in 2x50 mL tubes (3000 g, 3 372"
min), remove the supernatant, place on ice 373"
4. Resuspend each pellet in 500 µL 10% TCA (w/v; i.e. 0.61 N), pool into a 1.5 mL 374"
tube 375"
5. Leave on ice for at least 10 min (up to a few days) 376"
6. Prepare antibody-coupled beads for the immunoprecipitation. Take 50 µL of Protein-377"
G-coupled Sepharose slurry (see Note 10), wash in 1 mL IP dilution buffer, 378"
resuspend in 1 mL IP dilution buffer and use the appropriate amount of antibodies 379"
required for immunoprecipitation. Incubate for ≥1h at 4°C on a rotating wheel. 380"
18"
7. Pool the precipitated cells into one single 1.5 mL tube 381"
8. Pellet the precipitated cells: 1 min, 13 000 g at room temperature. 382"
9. Resuspend the precipitated cells with 100 µL of 10% TCA by pipetting up and down 383"
10. Add glass beads up to 1-2 mm below the meniscus 384"
11. Lyse cells on a vortex equipped with a microtube foam insert for 20 min at 4°C.  385"
12. After lysis, open the cap, poke a small hole at the bottom of the tube using a needle, 386"
place into a clean 1.5-mL tube to collect the lysate, and close the cap 387"
13. Centrifuge for a few seconds on a mini-centrifuge to collect the lysate and leave the 388"
beads in the upper tube. Discard the tube with the beads (they should be dry). The 389"
glass beads can be washed with 200 µL of cold 10% TCA if necessary, in this case, 390"
repeat the spin and pool with the first lysate.  391"
14. Centrifuge the lysate for 1 min at 13 000 g at RT.  392"
15. Remove as much supernatant as possible.  393"
16. Wash the pellet with 1 mL ice-cold acetone (100%) (see Note 11). 394"
17. Spin down for 1 min at 13 000 g, at 4°C.  395"
18. Discard supernatant. Let at room temperature with cap open until acetone has 396"
evaporated completely. 397"
19. Resuspend in 100 µL buffer B0. Make sure that the sample is blue (i.e. sample is not 398"
acidic). If the sample is yellow, add increments of 1 µL Tris-HCl 1M pH 7.5 until 399"
the pH is neutralized. 400"
20. Denature the sample at the desired temperature (37°C-95°C) for 5-10 min in a 401"
thermomixer. 402"
21. Spin down unsolubilized material by centrifuging for 5 min at 16,000 g, at room 403"
temperature 404"
22. Transfer the supernatant to a clean tube. 405"
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23. Add 400 µL of IP dilution buffer. 406"
24. Keep 50 µL aside for the “input” fraction ; keep on ice 407"
25. Spin down the antibody-coated beads (see step 6) for 1 min at 300 g (4°C) and 408"
remove the supernatant. 409"
26. Add the protein sample prepared in step 23 to the antibody-coated beads 410"
27. Incubate on a rotating wheel at 4° C for 2h. 411"
28. Spin down the beads for 1 min at 300 g (4°C). 412"
29. Take 50 µL of the supernatant and keep 50 µL aside for the “unbound” fraction; 413"
keep on ice. 414"
30. Carefully remove and discard remaining supernatant. 415"
31. 1st wash: Resuspend the beads in 1 mL buffer B1, and spin down the beads for 1 min 416"
at 300 g (4°C). 417"
32. Repeat the 1st wash. 418"
33. 2nd wash: Resuspend the beads in 1 mL buffer B2 and spin down the beads for 1 min 419"
at 300 g (4°C). 420"
34. Repeat the 2nd wash. 421"
35. 3rd wash: Resuspend the beads in 1 mL buffer B3 and spin down the beads for 1 min 422"
at 300 g (4°C). 423"
36. Repeat the 3rd wash. 424"
37. Last wash: Resuspend the beads in 1 mL buffer B4, and spin down the beads for 1 425"
min at 300 g (4°C). 426"
38. Repeat the last wash, and remove as much supernatant as possible. 427"
39. Add 50 µL of 1X sample buffer to the beads. 428"
40. To the “input” and “unbound” fractions, add 12.5 µL of 5X Laemmli sample buffer 429"
44. Denature at the desired temperature (37°C-95°C) for 5-10 min. 430"
20"
41. Load 7 µL of input / unbound fractions as prepared above, and 3-7 µL of the eluate 431"
(depending on the expression level of the protein and its rate of ubiquitylation).  432"
42. Blot with the antibody against the protein of interest or its epitope, to evaluate the 433"
efficiency of the immunoprecipitation, and with anti-Ubiquitin antibodies (1/10000 434"
mouse monocolonal P4D1 antibody: sc-8017, Santa Cruz Biotech) to reveal Ub 435"
conjugates. (see Note 12).  436"
 437"
3.4. Tandem purification of a protein in denaturing conditions for the identification of 438"
ubiquitin-conjugated sites 439"
Once ubiquitylation of a protein has been documented, a traditional approach to understand 440"
the consequences of this modification resides in identifying the sites targeted for 441"
ubiquitylation, followed by their mutation to evaluate the outcome of the lack of 442"
ubiquitylation on the protein’s stability or function. 443"
This protocol is based on a two-step purification. It involves the use of pBG1805-derived 444"
constructs (URA3-based) [29], in which all yeast genes have been cloned and that are 445"
commercially available. This allows the galactose-driven expression of the protein of 446"
interest tagged at its C-terminus with multiple epitopes: 6xHis, HA, and a ProtA (ZZ 447"
domains) preceded by a Protease 3C cleavage site (the size of the tag is 19 kDa). The first 448"
step is a regular immunoprecipitation in native conditions using anti-HA antibodies, 449"
followed by a Ni-NTA-based purification of the His-tag in denaturing conditions. It allows 450"
to purify the protein (both ubiquitylated and non-ubiquitylated, see Figure 4) for further, 451"
mass-spectrometry based, identification of the ubiquitylation sites (See note 13). Note that 452"
Protein A itself can be ubiquitylated in yeast cells (S. Léon, unpublished results). It is 453"
therefore necessary to identify the ubiquitylated sites by mass spectrometry to make sure 454"
that ubiquitin is carried on the substrate, and not the tag. Consequently, this protocol should 455"
21"
merely be used to identify the ubiquitylation sites, and not to prove that a protein is 456"
ubiquitylated. 457"
 DAY 1. Preculture: in the morning, inoculate freshly streaked yeast cells in 10 mL synthetic 458"
glucose medium lacking uracil.  459"
1. In the evening, measure the OD600 of the cultures and inoculate the yeast cells in 180 460"
mL synthetic raffinose medium, at OD600= 0.004. Grow overnight under agitation 461"
(200 rpm) at 30°C.  462"
2. DAY 2. Measure the OD600 of the cultures. The cultures should have reached an 463"
OD600 of ~0.3-0.5.  464"
3. Add galactose (2% final) in the medium for the desired amount of time (see Note 14)  465"
4. Measure the OD of the culture (see Note 2). 466"
5. Spin down the equivalent of 150 OD units of cells at 3000 g, 3 min at room 467"
temperature 468"
6. Remove the supernatant, resuspend the pellet in 10 mL cold water 469"
7. Spin down for 30 sec at 13,000 g, 4°C. 470"
8. Discard supernatant and keep the pellet on ice. 471"
9. Prepare antibody-coupled beads for the immunoprecipitation (see step 23). Take 200 472"
µL of Protein-G-coupled Sepharose slurry, wash in 1 mL IP lysis buffer, resuspend 473"
in 1 mL IP lysis buffer and use the appropriate amount of antibodies required for 474"
immunoprecipitation (e.g. 10 µL of mouse monoclonal F7 antibody: sc-7392 from 475"
Santa Cruz Biotech). Incubate for ≥1h at 4°C on a rotating wheel. 476"
10. Resuspend the pellet in 2.5 mL IP lysis buffer containing protease inhibitors (yeast 477"
protease inhibitor cocktail, 1 mM PMSF, 10 mM N-ethylmaleimide, 100 µM MG-478"
132). 479"
11. Dispatch the resuspended pellet in 5 x 600 µL fractions, in 1.5 mL tubes  480"
22"
12. Add glass beads (0.4-0.6 mm) up to 1-2 mm below the meniscus. 481"
13. Lyse cells on a vortex equipped with a microtube foam insert for 4 x 30 sec at 4°C 482"
(cold room), with 1 min incubation on ice between each pulse.! 483"
14. After lysis, in the cold room, open the tubes, poke a small hole at the bottom using a 484"
needle, place into a clean 1.5-mL tube to collect the lysate, and close the cap 485"
15. In the cold room, centrifuge for a few seconds on a mini-centrifuge to collect the 486"
lysate and leave the beads in the upper tube. Discard the tube with the beads (they 487"
should be dry).  488"
16. Pool lysates in a clean, cold centrifugation tube 489"
17. To the lysate, add 100 µL of a 25% solution of Triton-X 100, and invert to mix. (see 490"
Note 15). 491"
18. Let solubilize on ice for 10 min. 492"
19. Centrifuge the lysate for 5 min at 3 000 g at 4°C.  493"
20. Transfer supernatant to a clean, cold 15-mL tube and keep on ice. 494"
21. Keep 100 µL aside for the “input 1” fraction, keep on ice.  495"
22. Spin down the beads coupled to antibodies (step 10) for 30 sec at 1000 g, 4°C. 496"
23. Discard the beads’ supernatant. 497"
24. Add the beads to the lysate. 498"
25. Incubate on a rotating wheel at 4° C for 3h. 499"
26. Spin down the beads for 30 sec at 1000 g, 4°C. 500"
27. Keep 100 µL of the supernatant aside for the “unbound 1” fraction, keep on ice.  501"
28. Discard remaining supernatant. 502"
29. Add 1 mL of IP lysis buffer to the beads 503"
30. Transfer to a cold, 1.5 mL tube 504"
31. Incubate on a rotating wheel at 4° C for 10 min. 505"
23"
32. Spin down the beads for 30 sec at 1000 g, 4°C. Discard supernatant. 506"
33. Repeat the wash twice and carefully remove supernatant.  507"
34. Add 1 mL of urea buffer 508"
35. Incubate for 5 min at room temperature under agitation (e.g. in a thermomixer, 1000 509"
rpm) 510"
36. Open the tube, poke a small hole at the bottom of the tube using a needle, place into 511"
a clean 1.5-mL tube to collect the sample, and close the cap 512"
37. Centrifuge for a few seconds on a mini-centrifuge to collect the eluate and leave the 513"
beads in the upper tube. Discard the tube with the beads (they should be dry).  514"
38. Keep 30 µL of the eluate aside for the “input 2” fraction, keep on ice. 515"
39. To the remaining sample, add 500 µL Ni-NTA beads prewashed in urea buffer 516"
40. Incubate overnight on a rotating wheel at 4°C. 517"
41. To the “Input 1”, “Unbound 1” and “Input 2” fractions (steps 21, 27 and 38), add 1/5 518"
volume of 5x sample buffer, denature all samples at 55°C for 10 min and store at -519"
20°C. 520"
42. DAY 3. Spin down the beads (see step 40) for 30 sec at 1000 g, 4°C. 521"
43. Keep 30 µL aside for the “unbound 2” fraction, keep on ice. 522"
44. Discard remaining supernatant. 523"
45. Add 2.5 mL of Urea buffer to the beads, incubate on a rotating wheel at 4° C for 10 524"
min. 525"
46. Spin down the beads for 30 sec at 1000 g, 4°C. Discard supernatant. 526"
47. Repeat steps 45-46 and carefully remove supernatant.  527"
48. Add 1 mL of Urea buffer to the beads, and transfer to a 1.5 mL tube 528"
49. Incubate on a rotating wheel at 4° C for 10 min. 529"
24"
50. Spin down the beads for 30 sec at 1000 g, 4°C. Discard as much supernatant as 530"
possible. 531"
51. Add 100 µL of Urea elution buffer. 532"
52. Incubate for 5 min at room temperature under agitation (e.g. in a thermomixer, 1000 533"
rpm) 534"
53. Open the tube, poke a small hole at the bottom of the tube using a needle, place into 535"
a clean 1.5-mL tube to collect the eluate, and close the cap 536"
54. Centrifuge for a few seconds on a mini-centrifuge to collect the sample and leave the 537"
beads in the upper tube. Discard the tube with the beads (they should be dry).  538"
55. The total volume of the eluate (incl. the bed volume of the beads) should be 539"
approximately 175 µL.  540"
56. To the “unbound 2” and the “eluate” samples (steps 43 and 55), add 1/5 volume of 541"
5x sample buffer. 542"
57. Denature all samples (input 1, output 1, input 2, output 2, eluate) at 55°C for 10 min. 543"
58. Load 5 µL of input 1, output 1, input 2, output 2 and 10 µL of the final elution onto 544"
an SDS-PAGE gel.  545"
59. Blot with the antibody against your protein of interest or its epitope, to evaluate the 546"
purification procedure, and with anti-Ubiquitin antibodies (1/10000 mouse 547"
monocolonal P4D1 antibody: sc-8017, Santa Cruz Biotech) to reveal Ub conjugates. 548"
 549"
3.5 Identification of ubiquitylated sites within a protein of interest by a genetic 550"
approach 551"
Ubiquitin conjugation can occur at defined sites within a protein, and the identification of 552"
those sites (e.g. using the approach described in the above section) can help to generate non-553"
ubiquitylatable mutants after its/their mutation. However, the mutation of the target lysine is 554"
25"
sometimes compensated by the ubiquitylation of yet another site, because ubiquitylation can 555"
show little specificity towards the sites targeted [30]. Therefore, we describe a mutant-based 556"
approach that should lead to a construct that is not ubiquitylatable, regardless of the prior 557"
identification of the ubiquitylation sites, that we successfully used in the past [23]. This is 558"
based on a synthetic version of the ORFs encoding your protein of interest, in which all 559"
lysine residues have been substituted to arginine (K0 construct) (Figure 5A). Then, 560"
endogenous restriction sites can be used to construct chimeras. If no restriction sites are 561"
available, silent restriction sites should be introduced at various places within the sequence 562"
when designing the construct for gene synthesis, in which case a synthetic WT ORF must 563"
also be ordered, with the same restriction sites. The ubiquitylation of the resulting chimeras 564"
can be evaluated individually, to narrow down to the region and/or sites that are targeted by 565"
ubiquitylation (Figure 5B). 566"
Although it involves several cloning steps, this approach is still fairly efficient when dealing 567"
with proteins carrying many lysines. Note that this approach requires that the ubiquitylated 568"
site(s) lie(s) within a defined region of the primary structure of a protein. Below, we provide 569"
the general directions to properly map the ubiquitylated site(s) using this approach. 570"
1. Order synthetic gene versions encoding the protein of interest: WT and K0. Consider 571"
adding silent restriction sites within the sequence that are not present on the plasmid in 572"
which these synthetic genes will be cloned. 573"
2. Clone the synthetic genes in the plasmid of interest. It is advisable to use a plasmid 574"
allowing the expression of epitope-tagged protein, even if antibodies directed against the 575"
protein are available, because the KR mutations may affect the antigenicity of the protein. 576"
3. Assay for the ubiquitylation of the WT construct and the K0 mutant. The K0 should have 577"
lost all traces of ubiquitylation, if ubiquitin is conjugated on a lysine. 578"
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4. Construct chimeras (Nt-WT/Ct-K0 and Nt-K0/Ct-WT) and assay again the ubiquitylation 579"
of the chimeric proteins. The disappearance of ubiquitylated species for one of these 580"
constructs indicates that the target lysine(s) are contained within those that have been 581"
mutated. (see Note 16).  582"
5. Prepare additional chimeras to narrow down to the minimal region. 583"
6. If the density of lysines within the initial sequence is such that the final construct still 584"
bears several lysine residues, then site-directed mutagenesis can be used to further 585"
discriminate between each of those. 586"
3.6. Studying the topology of ubiquitin modification  587"
When dealing with a polyubiquitylated substrate, it may be interesting to determine the 588"
topology of the ubiquitin chain, because the various structures obtained through various 589"
ubiquitin linkages will lead to various functional outcomes.  590"
Various tools have been developed to do so, such as antibodies directed against the most 591"
abundant polyubiquitin chain linkages, namely K48- and K63-linked polyubiquitin, whose 592"
use has already been described [31]. The development of tandem-ubiquitin binding entities 593"
(TUBEs) [32,33] and other sensor proteins[34], consisting of multiple ubiquitin-binding 594"
domains, also allow the purification of substrates that are polyubiquitylated with various 595"
topologies and are commercially available. 596"
An alternative approach consists in using ubiquitin mutants in which either of the ubiquitin 597"
lysine residues have been mutated into an arginine, to hamper the ability to make a chain. 598"
These chain-terminating mutants can be individually overexpressed in the context of a wild-599"
type strain in which these mutants will act as dominant-negatives, as previously described 600"
[24]. Instead, here, we provide an example of the use of a set of yeast strains (“SUB” 601"
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strains) engineered by the Finley lab, in which all endogenous ubiquitin genes have been 602"
disrupted and complemented with a plasmid encoding either WT or lysine point-mutants of 603"
ubiquitin [5]. Below are guidelines on how to use these strains to determine ubiquitin 604"
linkage. Note that this approach is limited to the study of non-K48-based polyubiquitin 605"
chain substrates, because the expression of a K48R mutant in yeast as a sole source of 606"
ubiquitin is not viable [35]. For this specific case, the overexpression of Ub-K48R mutant in 607"
the context of a wild-type strain is therefore preferable [24]. Also, because the ubiquitin is 608"
not tagged in these strains, it cannot be purified by Ni-NTA based purification. Therefore, 609"
the analysis relies on the ability to see protein ubiquitylation on a crude extract (section 3.1) 610"
(Figure 6). Alternatively, the protein may be purified from each of these strains by 611"
denaturing IP, followed by a western blot using anti-ubiquitin antibodies as described in 612"
section 3.3. 613"
1. Transform the SUB strains with an URA3-based plasmid expressing a tagged version 614"
of the protein of interest using standard yeast transformation procedure. These 615"
includes SUB280 (WT ubiquitin), SUB515 (K6R Ub), SUB516 (K11R), SUB517 616"
(K27R), SUB518 (K29R), SUB519 (K33R), and SUB413 (K63 Ub) [5] (see Note 617"
17).  618"
2. Grow cells as described in section 3.1 (for crude extracts) or in section 3.3 (for 619"
denaturing IPs), in synthetic medium lacking uracil, starting at OD=0.010 for 620"
SUB280 and OD=0.020 for the mutants. 621"
3. For each strain, perform either a crude extract as described in section 3.1, or a 622"
denaturing IP as described in section 3.3 623"
4. Load samples on SDS-PAGE. 624"
5. Blot with the antibodies used to detect the protein of interest. 625"
 626"
28"
4. Notes 627"
1. The presence of 0.02% glucose allows a faster initiation of growth in raffinose 628"
medium.  629"
2. Cells will not lyse efficiently if they are not in exponential phase. We advise never to 630"
reach an OD>1.0.  631"
3. For proteins suspected to be modified by a K48-linked polyubiquitin chain, and/or to 632"
be proteasomal substrates, the treatment of cells with a proteasome inhibitor (eg. MG132, 633"
100 µM final) prior harvest can lead to their stabilization, sometimes in its ubiquitylated 634"
form (although this is usually counteracted by the presence of endogenous ubiquitin 635"
isopeptidases). However, the use of MG132 in yeast cultures at this concentration is only 636"
efficient in strains in which either PDR5 or ERG6 are disrupted, leading to an increased 637"
permeability to various drugs [36,37]. An alternative method to promote the efficiency of 638"
MG-132 in WT yeast strains has been described and is based on the use of a different culture 639"
medium [38]. 640"
4. This step is essential, because His-tagged proteins will not bind to Ni-NTA beads in 641"
acidic conditions. 642"
5. A pipette tip can be used too, but we advise not to pipette up and down because the 643"
pellet is sticky. 644"
6. The guanidine-HCl in buffer A may precipitate upon sample cooling. 645"
7. Do not incubate the beads with buffer A for too long, because they will titrate the 646"
imidazole in buffer A, which may hinder their ability to bind to His-tagged proteins later on. 647"
8. Preferentially use precast gradient gels (eg. NuPAGE® 4-12%, Bis-Tris, Life 648"
Technologies).  649"
9. Make sure that samples do not run out of the gel, because His-tagged ubiquitin is 650"
about 10 kDa and will be used as a purification control. 651"
29"
10. It is advised to use Protein G- rather than Protein A-coupled beads except when the 652"
source of the antibody is guinea pig. Neither Protein A nor Protein G bind chicken IgY. 653"
Alternatively, when using HA-tagged proteins, use the ready-to-use anti-HA affinity matrix 654"
(Roche): use 30 µL, resuspend in 1 mL IP dilution buffer and keep on ice. 655"
11. The use of a water-bath sonicator to resuspend the pellet helps for the final 656"
solubilization of the sample. 657"
12. Because of the presence of antibodies in the immunoprecipitate, we advise to use 658"
antibodies to ubiquitin that are directly coupled to HRP to avoid the use of a secondary 659"
antibody (e.g. mouse monoclonal P4D1 antibody: sc-8017 HRP, Santa Cruz Biotech; use at 660"
1/2000). 661"
13. Identifying post-translational modification sites by mass spectrometry can be 662"
hindered by the spacing of Arg/Lys residues, at which the cleavage with trypsin occurs 663"
within the protein of interest. Tryptic fragments that are either too long or too short will not 664"
be analyzed, leading to a poor coverage and eventually, the inability to detect the post-665"
translational modification. The coverage of a given protein by mass spectrometry can be 666"
visualized in repository databases, such as the Global Proteome Machine Database 667"
(http://gpmdb.thegpm.org). In this case, other proteases than trypsin should be considered 668"
prior to MS analysis. 669"
14. The plasmid used is a 2µ-based (high-copy) plasmid, and the expression of the 670"
protein is driven by the strong galactose-inducible promoter. This can lead to a massive 671"
overexpression of the protein, and the ubiquitylation detected may not be physiologically 672"
relevant. To circumvent this problem, the expression level of the protein at various times 673"
after galactose induction can be checked and compared with endogenous protein level. 674"
Protein expression can usually be observed within 15 min of galactose induction. 675"
15. Steps 17 and 18 are dispensable if dealing with a soluble protein. Adding TX-100 676"
30"
may lead to smears when visualizing the protein of interest by western blot. Note that 1% 677"
TX-100 solubilizes many membrane proteins, but not all, so this should be checked prior to 678"
the experiment. 679"
16. If both chimeric proteins appear ubiquitylated, then it is likely that the protein is 680"
ubiquitylated on multiple sites throughout the primary structure of the protein, or that 681"
ubiquitylation can occur on any of those sites. In both cases, this approach should be 682"
discontinued, and we advise to initiate a mapping of the ubiquitylated lysines using 683"
biochemical purification and mass spectrometry (see section 3.4). 684"
17. Note that only the URA3 gene can be used for selection of transformants in the SUB 685"
strains genetic backgrounds. 686"
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Figure captions. 831"
Figure 1. Obtaining evidence of ubiquitylation on crude extracts. Protein extracts from 832"
wild-type (BY4741) cells expressing the protein Ear1 tagged with mCherry (pSL22) 833"
[39] together with either pCUP1:Ub (pRS426-based plasmid: pRHT79; left) or 834"
pCUP1-His-Ub (pJD421; right) [16] were prepared as described in the text, 835"
electrophoresed on SDS-PAGE and blotted with monoclonal anti-DsRed antibodies 836"
(Clontech). The upper band observed on top of Ear1-mCh (gray arrowhead) is shifted 837"
up in apparent size when expressing His-tagged ubiquitin (black arrowhead). 838"
Figure 2. Purification of the endogenously, polyhistidine-tagged protein Snf1 on Ni-839"
NTA column in the absence of His-tagged ubiquitin. Proteins from a WT strain 840"
(BY4741) expressing Snf1-HA from a plasmid (pSL204) where prepared as described 841"
and purified on Ni-NTA resin in the absence of His-tagged ubiquitin. Equal amounts 842"
of extract (input, 1st lane) and unbound fraction (2nd lane) were loaded, showing the 843"
total depletion of Snf1, which is recovered in the eluate (3rd lane). Phosphoglycerate 844"
kinase (PGK) is used as a control and does not bind to the beads. Other proteins that 845"
may show a similar behavior are displayed in Table 1. 846"
Figure 3. Purification of ubiquitin conjugates using polyHis-tagged ubiquitin. Protein 847"
extracts from WT cells (BY4741) expressing either Ub or His-tagged Ub (see Figure 848"
1) were prepared and treated as described for the purification of His-tagged ubiquitin. 849"
A. Ponceau S staining of the nitrocellulose membrane after transfer of the indicated 850"
sample, showing the purification of His-Ub in the eluate fraction (El) (arrow). B. 851"
Western blot using anti-ubiquitin antibodies on a similar experiment. The gel shows 852"
ubiquitin dimers (Ub2) in both cell types, and His-Ub+Ub dimers in cells expressing 853"
His-Ub. C.  Example of a purification of His-tagged ubiquitin from yeast cells grown 854"
36"
either in lactate or glucose medium and expressing the arrestin-related protein Rod1 855"
tagged with GFP. Displayed are the “input “ (Inp) and eluate fractions (El.). Rod1 is 856"
phosphorylated in lactate medium (asterisk) and becomes ubiquitylated rapidly after 857"
glucose addition (black circle) (See also [23]). 858"
Figure 4. Tandem purification of a protein in denaturing conditions for the 859"
identification of ubiquitin-conjugated sites. A. WT cells (BY4741) expressing the 860"
galactose-inducible Ear1-His6-HA-ProtA construct were subjected to a double 861"
purification as described. First, an immunoprecipitation using anti-HA antibodies was 862"
performed on a crude extract in native conditions (input 1 and unbound 1). The eluate 863"
of this immunoprecipiattion was used as the input fraction (input 2) for the second, 864"
Ni-NTA based purification of the protein in denaturing conditions (unbound 2 and 865"
final eluate). A western blot using anti-HA antibodies allows to evaluate the 866"
purification procedure. B. From the same fraction, 1 µL or 25 µL of elauet were 867"
loaded on the same gel. The gel was cut, and the left part was subjected to a western 868"
blot using anti-HA antibodies, whereas the right part was used for colloidal blue 869"
staining, showing the purity of the protein obtained. 870"
Figure 5. Identification of ubiquitylated sites within a protein of interest by a genetic 871"
approach. A. Example of the method: identification of the ubiquitylated region 872"
within the arrestin-related protein, Rod1, using a synthetic construct in which all 873"
lysines have been mutated (K0) and its derived chimeric constructs [23]. B. Western 874"
blot showing the ubiquitylation status of several of the chimeric constructs depicted in 875"
A. The asterisk indicates phosphorylated Rod1, which is only observed when yeast 876"
cells are grown in the absence of glucose, such as in lactate medium (Lac) [23]. The 877"
black circles indicate Rod1 ubiquitylation, which occurs only after glucose exposure 878"
37"
and for constructs in which the ubiquitylation site is still intact. PGK is used as a 879"
loading control. 880"
Figure 6. Studying the topology of ubiquitin modification. An example of the use of the 881"
SUB strains (which express K-to-R ubiquitin mutants) to gain information on the topology 882"
of the ubiquitin modification on a substrate (here, the endosomal Rsp5 adaptor protein, 883"
Ear1) . Black arrowheads: Ear1 ubiquitylated adducts. White arrow: the ubiquitin 884"
modification appears as a single band in the SUB413 strain, suggesting that Ear1 is 885"
polyubiquitylated with a short K63 chain (for more details, see also [40]). PGK is used as a 886"
loading control. 887"






